Authors
Latest:
St. John’s Wort Could Show Benefit in Major Depressive DisorderPatients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Latest:
Is the 340B Hospitals Battle at the Supreme Court Over?Decision on payment reductions looks fleeting as ruling also provides HHS with instructions on cost-cutting goals.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical CancerApproval of a novel antibody-drug conjugate ushers in new second-line option.
Latest:
Novel Treatments Could Turn the Tide for Alzheimer DiseaseAnti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.
Latest:
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood CancerAdvances, challenges, and promising innovations emerge.
Latest:
5 Quick Tips to Create a Transformative Advanced Pharmacy Practice Experiences RotationWhat many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.
Latest:
Glucophage Will Activate the Same Pathway as Sprint Exercise to Reduce AppetiteThe oral medication activates an “anti-hunger” molecule which may prevent people from overeating.
Latest:
The Pharmacist’s Role: Opioid-related Risks With a Psychiatric DrugPharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Latest:
Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care ConsiderationsAtopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.
Latest:
The Role of Erenumab (Aimovig) in Treating Episodic, Chronic MigrainesErenumab (Aimovig) was the first anti-CGRP agent approved by the FDA for migraine prophylaxis.
Latest:
Concluding Remarks: Collaborative Expertise in an Era of Emerging Cancer TherapiesPanelists discuss how there have been many new agents being studied and released at the current time and how the development of these agents is moving at a rapid pace. The adverse effect profiles of newer antibody-drug conjugates create a greater opportunity for pharmacists to be involved in toxicity management.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
Breaking Silos: How Health Systems and Manufacturers Can Drive Progress TogetherVanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.
Latest:
Find New Career Paths and Opportunities for AdvancementMy own experience has illustrated how embracing change can lead to growth.
Latest:
Pharmacists Are Over-Looked Travel SpecialistsAs the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.
Latest:
HOPA 2025: Insights Into Post-Transplant Cyclophosphamide Use for Graft-Versus-Host Disease PreventionLauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.
Latest:
USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ DiseaseAchieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Latest:
What’s Next in Health Care: How Pharmacies Can Help Serve Their Communities BetterKey trends such as consolidation create an opportunity for independent pharmacies with a community-based approach.
Latest:
HER2-Targeted Treatments for NSCLC: Introducing ZongertinibCurrently, standard first-line chemotherapy with or without immunotherapy for patients with non-small-cell lung cancer (NSCLC) with HER2 mutations has limited efficacy.
Latest:
New Drug Overview: Aducanumab-Avwa (Aduhelm) for Alzheimer DiseaseAducanumab-avwa is a monoclonal antibody that is the first treatment of its class designed to target the amyloid β protein, a biomarker of Alzheimer disease and other dementias.
Latest:
Industry Trend Report: Consumer Comfort With Pharmacy-Provided Vaccinations and Services GrowsPharmacies can reach patients who are not receiving vaccines from a pharmacy but are willing to receive them.
Latest:
Personalized Treatments Advance Survival Outcomes for Patients With Lung CancerPrevention methods, including smoking cessation and public education, remain critical in combating the United States’ third most common cancer type.
Latest:
CDC and FDA Recommendations for SARS-CoV-2 Booster ShotsExperts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
Latest:
Improving Hypertension Management: Home Blood Pressure Monitoring and Medication AdherenceOne of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.
Latest:
Opinion: Clinical Trials Should Be Accessible to EverybodyA lack of access, awareness, and trust have led to a lack of affordability, effectiveness, and inclusivity.
Latest:
HOPA Fellow Reflects on Mentorship, Leadership, and the Future of Oncology PharmacyAlexandra Wolff, PharmD, BCOP, FHOPA, was awarded a fellow of HOPA at the 2025 annual meeting.
Latest:
Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy PracticeThe high acceptance rates of these interventions demonstrate the key role in optimizing patient care that clinical oncology pharmacists with access to medical records play.
